European flag

Jurnalul Ofícial
al Uniunii Europene

RO

Seria C


C/2026/1816

31.3.2026

Rezumatul deciziilor Uniunii Europene privind autorizațiile de introducere pe piață pentru medicamentele de la 1 februarie 2026 până la 28 februarie 2026

[Publicat în temeiul articolului 13 sau al articolului 38 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului  (1) sau al Articolul 5 din Regulamentul (UE) 2019/6 al Parlamentului European și al Consiliului  (2) ]

(C/2026/1816)

Emiterea unei autorizații de introducere pe piață (articolul 13 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului): Acceptat

Data deciziei

Denumirea medicamentului

DCI (Denumirea Comună Internațională)

Titularul autorizației de introducere pe piață

Numărul de înregistrare în Registrul comunitar

Formă farmaceutică

Codul ATC (Codul Anatomic-Terapeutic-Chimic)

Data notificării

10.2.2026

Gotenfia

golimumab

STADA Arzneimittel AG

Stadastraße 2-18, 61118 Bad Vilbel, Deutschland

EU/1/25/2009

Concentrat pentru soluţie injectabilă

L04AB06

12.2.2026

10.2.2026

Ranluspec

ranibizumab

Lupin Europe GmbH

Hanauer Landstraße 139-143, 60314 Frankfurt, Deutschland

EU/1/25/2012

Soluţie injectabilă

Soluţie injectabilă în seringă preumplută

S01LA04

17.2.2026

12.2.2026

Aumseqa

aumolertinib

SFL Pharmaceuticals Deutschland GmbH

Marie-Curie-Strasse 8, 79539 Loerrach, Deutschland

EU/1/25/2006

Comprimat filmat

L01EB11

13.2.2026

12.2.2026

EXDENSUR

depemokimab

GlaxoSmithKline Trading Services Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, D24 YK11, Ireland

EU/1/25/2007

Soluţie injectabilă

R03DX12

16.2.2026

12.2.2026

mNEXSPIKE

Vaccin cu ARNm împotriva COVID-19

MODERNA BIOTECH SPAIN, S.L.

C/ Julián Camarillo no 31, 28037 Madrid, España

EU/1/25/2010

Dispersie injectabilă

J07BN01

13.2.2026

12.2.2026

MYQORZO

aficamten

Cytokinetics (Ireland) Limited

45 Mespil Rd. Dublin D04 W2F1 Ireland

EU/1/25/2014

Comprimat filmat

Pending

13.2.2026

16.2.2026

ANKTIVA

nogapendekin alfa inbakicept

ImmunityBio Ireland Limited

6th Floor, 2 Grand Canal Square, Dublin 2, D02 A342, Ireland

EU/1/25/2002

Concentrat pentru suspensie intravezicală.

L03AC03

17.2.2026

20.2.2026

Deltyba

delamanid

Otsuka Novel Products GmbH

Erika-Mann-Straße 21, 80636 München, Deutschland

EU/1/13/875

Comprimat filmat

J04AK06

23.2.2026

Modificarea unei autorizații de introducere pe piață (articolul 13 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului): Acceptat

Data deciziei

Denumirea medicamentului

Titularul autorizației de introducere pe piață

Numărul de înregistrare în Registrul comunitar

Data notificării

4.2.2026

Actelsar HCT

Actavis Group PTC ehf.

Dalshraun 1, 220 Hafnarfjörður, Íceland

EU/1/13/817

6.2.2026

4.2.2026

Lytenava

Outlook Therapeutics NL B.V.

Strawinskylaan 569, 1077XX Amsterdam, Nederland

EU/1/24/1798

5.2.2026

4.2.2026

Nucala

GlaxoSmithKline Trading Services Limited

Riverwalk 12, Citywest Business Campus, Dublin 24, Ireland

EU/1/15/1043

5.2.2026

10.2.2026

Carbaglu

Recordati Rare Diseases

Tour Hekla, 52 Avenue Du General De Gaulle, 92800 Puteaux, France

EU/1/02/246

16.2.2026

10.2.2026

Casgevy

Vertex Pharmaceuticals (Ireland) Limited

Unit 49, Block 5, Northwood Court, Northwood Crescent, Dublin 9, D09 T665, Ireland

EU/1/23/1787

12.2.2026

10.2.2026

Emadine

Immedica Pharma AB

SE-113 63, Stockholm, Sverige

EU/1/98/095

11.2.2026

10.2.2026

Enspryng

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/21/1559

11.2.2026

10.2.2026

JEMPERLI

GlaxoSmithKline Trading Services Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, D24 YK11, Ireland

EU/1/21/1538

13.2.2026

10.2.2026

Kengrexal

Chiesi Farmaceutici S.p.A.

Via Palermo 26/A, 43122 Parma, Italia

EU/1/15/994

17.2.2026

10.2.2026

Myalepta

Chiesi Farmaceutici S.p.A.

Via Palermo 26/A, 43122 Parma, Italia

EU/1/18/1276

11.2.2026

10.2.2026

Relistor

Bausch Health Ireland Limited

3013 Lake Drive, Citywest Business Campus, Dublin 24, D24PPT3, Ireland

EU/1/08/463

13.2.2026

10.2.2026

Retsevmo

Eli Lilly Nederland B.V.

Orteliuslaan 1000, 3528 BD, Nederland

EU/1/20/1527

11.2.2026

10.2.2026

Uplizna

Amgen Europe B.V.

Minervum 7061, 4817 ZK Breda, Nederland

EU/1/21/1602

11.2.2026

10.2.2026

Vfend

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/02/212

11.2.2026

12.2.2026

Akynzeo

Helsinn Birex Pharmaceuticals Ltd

Damastown, Mulhuddart, Dublin 15, Ireland

EU/1/15/1001

13.2.2026

12.2.2026

Aptivus

Boehringer Ingelheim International GmbH

Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/05/315

15.2.2026

12.2.2026

Bronchitol

Pharmaxis Europe Limited

108 Q House, Furze Road, Sandyford, Dublin 18, D18AY29, Ireland

EU/1/12/760

16.2.2026

12.2.2026

Emblaveo

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/24/1808

13.2.2026

12.2.2026

EndolucinBeta

ITM Medical Isotopes GmbH

Lichtenbergstraße 1, 85748 Garching/München, Deutschland

EU/1/16/1105

13.2.2026

12.2.2026

Klisyri

Almirall, S.A.

Ronda General Mitre, 151, 08022 Barcelona, España

EU/1/21/1558

13.2.2026

12.2.2026

Mvabea

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/20/1445

13.2.2026

12.2.2026

Orladeyo

Biocryst Ireland Limited

Block 4, Harcourt Centre, Harcourt Road, Dublin 2, D02 HW77, Ireland

EU/1/21/1544

13.2.2026

12.2.2026

Pemazyre

Incyte Biosciences Distribution B.V.

Paasheuvelweg 25, 1105 BP Amsterdam, Nederland

EU/1/21/1535

13.2.2026

12.2.2026

Ponvory

LABORATOIRES JUVISE PHARMACEUTICALS

149 Boulevard Bataille de Stalingrad, 69100 Villeurbanne, France

EU/1/21/1550

18.2.2026

12.2.2026

Skyrizi

AbbVie Deutschland GmbH & Co. KG

Knollstrasse, 67061 Ludwigshafen, Deutschland

EU/1/19/1361

13.2.2026

12.2.2026

Veoza

Astellas Pharma Europe B.V.

Sylviusweg 62, 2333 BE Leiden, Nederland

EU/1/23/1771

17.2.2026

12.2.2026

Yondelis

Pharma Mar S.A.

Avenida de los Reyes 1, Polígono Industrial La Mina, 28770 Colmenar Viejo, Madrid, España

EU/1/07/417

18.2.2026

12.2.2026

Zynlonta

Swedish Orphan Biovitrum AB (publ)

112 76 Stockholm, Sverige

EU/1/22/1695

13.2.2026

16.2.2026

Abraxane

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

EU/1/07/428

17.2.2026

16.2.2026

SIMBRINZA

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/14/933

17.2.2026

16.2.2026

Strensiq

Alexion Europe SAS

103-105 rue Anatole France, 92300 Levallois-Perret, France

EU/1/15/1015

18.2.2026

16.2.2026

Wegovy

Novo Nordisk A/S

Novo Allé, 2880 Bagsvaerd, Danmark

EU/1/21/1608

17.2.2026

16.2.2026

Zabdeno

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/20/1444

17.2.2026

18.2.2026

Busulfan Fresenius Kabi

Fresenius Kabi Deutschland GmbH

Else-Kröner-Straße 1, 61352 Bad Homburg vor der Höhe, Deutschland

EU/1/14/951

19.2.2026

18.2.2026

Dimethyl fumarate Neuraxpharm

Neuraxpharm Pharmaceuticals, S.L.

Avda. Barcelona 69, 08970 Sant Joan Despí - Barcelona, España

EU/1/24/1810

23.2.2026

18.2.2026

Irbesartan Zentiva

Zentiva k.s.

U kabelovny 130, 102 37 Praha 10, Česká republika

EU/1/06/376

23.2.2026

18.2.2026

Jylamvo

Oresund Pharma ApS

Orient Plads 1, 2150 Nordhavn, Danmark

EU/1/17/1172

20.2.2026

18.2.2026

Kinzalmono

Bayer AG

D-51368 Leverkusen, Deutschland

EU/1/98/091

19.2.2026

18.2.2026

Livmarli

Mirum Pharmaceuticals International B.V.

Kingsfordweg 151, 1043 GR Amsterdam, Noord-Holland, Nederland

EU/1/22/1704

19.2.2026

18.2.2026

Micardis

Boehringer Ingelheim International GmbH

Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/98/090

19.2.2026

18.2.2026

Natpar

Takeda Pharmaceuticals International AG Ireland Branch

Block 2 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, D02 HW68, Ireland

EU/1/15/1078

20.2.2026

18.2.2026

Pritor

Bayer AG

D-51368 Leverkusen, Deutschland

EU/1/98/089

19.2.2026

18.2.2026

Xevudy

GlaxoSmithKline Trading Services Limited

Riverwalk 12, Citywest Business Campus, Dublin 24, Ireland

EU/1/21/1562

19.2.2026

20.2.2026

Rybrevant

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/21/1594

23.2.2026

23.2.2026

Afinitor

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/09/538

24.2.2026

23.2.2026

Atazanavir Krka

KRKA d d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/19/1353

25.2.2026

23.2.2026

Balversa

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/24/1841

24.2.2026

23.2.2026

Copalia

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/06/372

24.2.2026

23.2.2026

Dafiro

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/06/371

24.2.2026

23.2.2026

Evkeeza

Ultragenyx Germany GmbH

Rahel-Hirsch-Str. 10, 10557 Berlin, Deutschland

EU/1/21/1551

24.2.2026

23.2.2026

Kadcyla

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/13/885

24.2.2026

23.2.2026

Obgemsa

PIERRE FABRE MEDICAMENT

Les Cauquillous, 81500 Lavaur, France

EU/1/24/1822

2.3.2026

23.2.2026

Ravicti

Immedica Pharma AB

SE-113 63, Stockholm, Sverige

EU/1/15/1062

2.3.2026

23.2.2026

Sitagliptin Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

EU/1/22/1633

25.2.2026

23.2.2026

Tabrecta

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/22/1650

24.2.2026

23.2.2026

TAKHZYRO

Takeda Pharmaceuticals International AG Ireland Branch

Block 2 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, D02 HW68, Ireland

EU/1/18/1340

24.2.2026

23.2.2026

Telmisartan Actavis

Actavis Group PTC ehf.

Dalshraun 1, 220 Hafnarfjörður, Íceland

EU/1/10/639

25.2.2026

23.2.2026

Trazimera

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/18/1295

24.2.2026

23.2.2026

Vectibix

Amgen Europe B.V.

Minervum 7061, 4817 ZK Breda, Nederland

EU/1/07/423

24.2.2026

23.2.2026

Viagra

Upjohn EESV

Rivium Westlaan 142, 2909 LD Capelle aan den IJssel, Nederland

EU/1/98/077

10.3.2026

23.2.2026

Vokanamet

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/14/918

24.2.2026

23.2.2026

Wilzin

Recordati Rare Diseases

Tour Hekla, 52 avenue du Général de Gaulle, F-92800 Puteaux, France

EU/1/04/286

24.2.2026

25.2.2026

Bimzelx

UCB Pharma S.A.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België

EU/1/21/1575

2.3.2026

25.2.2026

Bortezomib Fresenius Kabi

Fresenius Kabi Deutschland GmbH

Else-Kröner-Straße 1, 61352 Bad Homburg vor der Höhe, Deutschland

EU/1/19/1397

26.2.2026

25.2.2026

Exforge HCT

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/09/569

26.2.2026

25.2.2026

Neoatricon

BrePco Biopharma Ltd.

Suite One, The Avenue, Beacon Court, Sandyford, Dublin D18HX31, Ireland

EU/1/24/1804

27.2.2026

25.2.2026

Nexium Control

Haleon Ireland Dungarvan Limited

Knockbrack,Dungarvan, Co. Waterford, Ireland

EU/1/13/860

3.3.2026

25.2.2026

Nimenrix

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/12/767

26.2.2026

25.2.2026

Orgovyx

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

EU/1/22/1642

26.2.2026

25.2.2026

Oslif Breezhaler

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/09/586

26.2.2026

25.2.2026

Strimvelis

Fondazione Telethon ETS

Via Varese 16/B, 00185 Roma, Italia

EU/1/16/1097

26.2.2026

25.2.2026

Suliqua

Sanofi Winthrop Industrie

82 avenue Raspail, 94250 Gentilly, France

EU/1/16/1157

26.2.2026

25.2.2026

Ultibro Breezhaler

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/13/862

26.2.2026

26.2.2026

Copalia HCT

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/09/575

27.2.2026

26.2.2026

Dafiro HCT

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/09/574

27.2.2026

26.2.2026

Exforge

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/06/370

27.2.2026

26.2.2026

Incellipan

Seqirus Netherlands B.V.

Paasheuvelweg 28, 1105 BJ Amsterdam, Nederland

EU/1/24/1807

2.3.2026

26.2.2026

Pepaxti

Oncopeptides AB (publ)

Luntmakargatan 46, 111 37 Stockholm, Sverige

EU/1/22/1669

3.3.2026

26.2.2026

Thiotepa Riemser

Esteve Pharmaceuticals GmbH

Hohenzollerndamm 150-151, 14199 Berlin, Deutschland

EU/1/21/1536

27.2.2026

Retragerea unei autorizații de introducere pe piață (articolul 13 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului)

Data deciziei

Denumirea medicamentului

Titularul autorizației de introducere pe piață

Numărul de înregistrare în Registrul comunitar

Data notificării

18.2.2026

Xevudy

GlaxoSmithKline Trading Services Limited

Riverwalk 12, Citywest Business Campus, Dublin 24, Ireland

EU/1/21/1562

20.2.2026

23.2.2026

Atazanavir Krka

KRKA d d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/19/1353

2.3.2026

23.2.2026

Fluad Tetra

Seqirus Netherlands B.V.

Paasheuvelweg 28, 1105 BJ Amsterdam, Nederland

EU/1/20/1433

24.2.2026

23.2.2026

Flucelvax Tetra

Seqirus Netherlands B.V.

Paasheuvelweg 28, 1105 BJ Amsterdam, Nederland

EU/1/18/1326

25.2.2026

23.2.2026

Zegalogue

Zealand Pharma A/S

Sydmarken 11, 2860 Soeborg, Danmark

EU/1/24/1829

24.2.2026

Emiterea unei autorizații de introducere pe piață (articolul 38 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului; Articolul 5 din Regulamentul (UE) 2019/6 al Parlamentului European și al Consiliului): Acceptat

Data deciziei

Denumirea medicamentului

DCI (Denumirea Comună Internațională)

Titularul autorizației de introducere pe piață

Numărul de înregistrare în Registrul comunitar

Formă farmaceutică

Codul ATC (Codul Anatomic-Terapeutic-Chimic)

Data notificării

25.2.2026

Lotilaner/Milbemycin Elanco

lotilaner / milbemicin oximă

Elanco GmbH

Heinz-Lohmann-Str. 4, 27472 Cuxhaven, Deutschland

EU/2/26/361

Tablete masticabile

QP54AB51

27.2.2026

Modificarea unei autorizații de introducere pe piață (articolul 38 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului; Articolul 5 din Regulamentul (UE) 2019/6 al Parlamentului European și al Consiliului): Acceptat

Data deciziei

Denumirea medicamentului

Titularul autorizației de introducere pe piață

Numărul de înregistrare în Registrul comunitar

Data notificării

16.2.2026

Mirataz

Dechra Regulatory B.V.

Handelsweg 25, 5531 AE Bladel, Nederland

EU/2/19/247

23.2.2026

Oricine este interesat să consulte raportul public de evaluare al medicamentului în cauză și deciziile aferente este invitat să contacteze:

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS


(1)   JO L 136, 30.4.2004, p. 1, ELI: https://data.europa.eu/eli/reg/2004/726/oj.

(2)   JO L 4, 7.1.2019, p. 43, ELI: https://data.europa.eu/eli/reg/2019/6/oj.


ELI: http://data.europa.eu/eli/C/2026/1816/oj

ISSN 1977-1029 (electronic edition)